Serial NT-proBNP testing can identify future HF risk: study

Doctors say persistent elevations in the cardiac biomarker may signal longer cumulative exposure to risk factors
Rachel Fieldhouse

Sustained elevations in NT-proBNP among asymptomatic middle-aged adults may predict heart failure and death from any cause, according to US doctors.

Results from their cohort study, which included 9800 patients with NT-proBNP measurements taken six years apart, suggest that levels above 125ng/L across both visits were associated with a 2.4-fold increased risk of incident heart failure (HF).